TBC1D22A-GRAMD4 Fusion FISH Probe
The TBC1D22A-GRAMD4 Fusion FISH Probe is used to confirm a fusion of the TBC1D22A and GRAMD4 genes. The fusion of the TBC1D22A and GRAMD4 genes has been associated with Breast Invasive Carcinoma, and Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TBC1D22A-GRAMD4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GRAMD4-20-AQAQ | 20 (40 μL) | 200 μL |
|
GRAMD4 Gene Summary
GRAMD4 is a mitochondrial effector of E2F1 (MIM 189971)-induced apoptosis (Stanelle et al., 2005 [PubMed 15565177]).[supplied by OMIM, Jan 2011]
Gene Name: GRAM Domain Containing 4
Chromosome: CHR22: 47022657 -47075688
Locus: 22q13.31
TBC1D22A Gene Summary
The TBC1 Domain Family Member 22A (TBC1D22A) gene is located on chr22 :47158517-47571342 at 22q13.31.
Gene Name: TBC1 Domain Family Member 22A
Chromosome: CHR22: 47158517 -47571342
Locus: 22q13.31
Gene Diseases
The TBC1D22A GRAMD4 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|